Isodiol International Inc. Announces Binding Agreement to Acquire 25% of Canadian National Pharma Group Inc.
06 déc. 2017 09h00 HE
|
Isodiol
VANCOUVER, British Columbia, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator...